Large Conization-Retrospective Monocentric Results for Fertility Preservation in Young Women with Early Stage Cervical Cancer.


Journal

Reproductive sciences (Thousand Oaks, Calif.)
ISSN: 1933-7205
Titre abrégé: Reprod Sci
Pays: United States
ID NLM: 101291249

Informations de publication

Date de publication:
03 2022
Historique:
received: 03 05 2021
accepted: 14 11 2021
pubmed: 1 12 2021
medline: 24 3 2022
entrez: 30 11 2021
Statut: ppublish

Résumé

The shorter cervical segment after classic radical trachelectomy (RT) imposes a number of pregnancy associated risk factors. In this aspect, large conization (LC) could be an oncologically safe alternative to RT in young women with early stage cervical cancer who want to spare their fertility. Our aim was to evaluate fertility-sparing surgical treatment of early stage cervical cancer after the introduction of LC. Our objectives were to assess surgical, oncological, fertility and obstetric outcomes. We retrospectively investigated oncological and fertility outcomes of patients who underwent LC in a large oncological single University centre between 2009 and 2014. Medical records were reviewed and analysed for surgical, oncological, fertility and obstetric outcomes. Postal questionnaires were collected to further evaluate and validate the fertility and obstetric outcomes. A total of 23 LCs were analysed. Seven patients had to undergo secondary radical hysterectomy after LC due to unclear resection margins. Nine of 16 women tried to conceive, of which all nine became pregnant. Seven patients underwent a prophylactic cerclage between 13 and 16 gestational weeks and seven women delivered 9 children; the majority of women conceived spontaneously. Follow-up time was a median of 3.9 years (2.6-8 years). There was no relapse of cervical cancer in the investigated timeframe. Early stage cervical cancers treated by LC are associated with excellent oncological outcomes. LC appears to be a safe option for eligible women who intend to maintain their fertility.

Identifiants

pubmed: 34845668
doi: 10.1007/s43032-021-00807-9
pii: 10.1007/s43032-021-00807-9
pmc: PMC8863693
doi:

Banques de données

DRKS
['DRKS00012380']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

791-799

Informations de copyright

© 2021. The Author(s).

Références

Oncol Rep. 2013 Dec;30(6):2545-54
pubmed: 24065029
Am J Obstet Gynecol. 2009 Oct;201(4):375.e1-8
pubmed: 19788970
Cancer. 2000 Apr 15;88(8):1877-82
pubmed: 10760765
Gynecol Oncol. 2008 Nov;111(2 Suppl):S116-20
pubmed: 18725167
J Obstet Gynaecol Br Emp. 1957 Oct;64(5):712-4
pubmed: 13476263
BJOG. 2012 Sep;119(10):1247-55
pubmed: 22804838
PLoS One. 2018 Jan 31;13(1):e0189847
pubmed: 29385139
Int J Gynecol Cancer. 2016 May;26(4):758-62
pubmed: 26841285
Gynecol Oncol. 2012 Dec;127(3):484-8
pubmed: 22935472
Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S152-6
pubmed: 16140367
Radiat Oncol. 2021 Mar 20;16(1):54
pubmed: 33743714
Oncotarget. 2017 Jul 11;8(28):46580-46592
pubmed: 28418849
BMJ. 2014 Nov 05;349:g6223
pubmed: 25378384
Lancet Oncol. 2011 Feb;12(2):192-200
pubmed: 20619737
Lancet Oncol. 2016 Jun;17(6):e240-e253
pubmed: 27299280
Gynecol Oncol. 2018 Jul;150(1):44-49
pubmed: 29776598
Gynecol Oncol. 2011 Jun 1;121(3):565-70
pubmed: 21334051
Int J Gynaecol Obstet. 1995 Aug;50(2):175-8
pubmed: 7589754
Case Rep Surg. 2013;2013:207191
pubmed: 24223319
Gynecol Oncol. 2011 May 1;121(2):290-7
pubmed: 21255824
Fertil Steril. 2016 Oct;106(5):1195-1211.e5
pubmed: 27430207
Arch Gynecol Obstet. 2019 Apr;299(4):1033-1041
pubmed: 30488281
Int J Gynecol Cancer. 2011 Nov;21(8):1458-64
pubmed: 21701392
Gynecol Oncol. 2013 Oct;131(1):77-82
pubmed: 23769758
Int Urogynecol J. 2014 Apr;25(4):457-64
pubmed: 24170226
Int J Gynecol Cancer. 2013 Jun;23(5):916-22
pubmed: 23669441
Radiother Oncol. 2018 Jun;127(3):404-416
pubmed: 29728273
Int J Gynaecol Obstet. 2019 Apr;145(1):129-135
pubmed: 30656645
Int J Gynecol Cancer. 2016 Oct;26(8):1510-4
pubmed: 27465895
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593

Auteurs

Christos Tsaousidis (C)

Women's Center Bern, Lindenhofgruppe, Bern, Switzerland.

Bernhard Kraemer (B)

Department of Women's Health, Women's University Hospital, Tuebingen University Hospital, Calwerstr. 7, 72076, Tuebingen, Germany.

Stefan Kommoss (S)

Department of Women's Health, Women's University Hospital, Tuebingen University Hospital, Calwerstr. 7, 72076, Tuebingen, Germany.

Andreas Hartkopf (A)

Department of Women's Health, Women's University Hospital, Tuebingen University Hospital, Calwerstr. 7, 72076, Tuebingen, Germany.

Sara Brucker (S)

Department of Women's Health, Women's University Hospital, Tuebingen University Hospital, Calwerstr. 7, 72076, Tuebingen, Germany.

Katrin Neis (K)

Department of Women's Health, Women's University Hospital, Tuebingen University Hospital, Calwerstr. 7, 72076, Tuebingen, Germany.

Juergen Andress (J)

Department of Women's Health, Women's University Hospital, Tuebingen University Hospital, Calwerstr. 7, 72076, Tuebingen, Germany.

Felix Neis (F)

Department of Women's Health, Women's University Hospital, Tuebingen University Hospital, Calwerstr. 7, 72076, Tuebingen, Germany. felix.neis@med.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH